JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.
暂无分享，去创建一个
J. Teruya-Feldstein | K. Yen | M. V. Vander Heiden | R. Levine | Efthymia Papalexi | A. Intlekofer | A. Shih | Allison N. Lau | Elizaveta Freinkman | Minal A. Patel | A. Chiu | R. Rampal | Jihae Ahn | A. McKenney | K. Shank | B. Spitzer | Amritha Varshini Hanasoge Somasundara | E. Akbay | R. Nagaraja | Mya Steadman | Franck Rapaport | Kwok-kin Wong | C. Thompson